-+ 0.00%
-+ 0.00%
-+ 0.00%

HOTH THERAPEUTICS REPORTS POSITIVE PRECLINICAL RESULTS FOR HT-KIT, A PRECISION ANTISENSE THERAPY TARGETING RARE AND AGGRESSIVE KIT-DRIVEN CANCERS

Reuters·05/12/2025 11:30:54

Please log in to view news